A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Dragonfly Therapeutics
Centre Oscar Lambret
Dana-Farber Cancer Institute
Sun Yat-sen University
Dana-Farber Cancer Institute
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)
NeoImmuneTech
University of Michigan Rogel Cancer Center
Rutgers, The State University of New Jersey
Zhejiang Cancer Hospital
Institute of Oncology Ljubljana
ARCAGY/ GINECO GROUP
University of Tennessee Graduate School of Medicine
University of Alabama at Birmingham
University of Iowa
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
Cedars-Sinai Medical Center
University Hospital, Ghent
Impact Therapeutics, Inc.
SN BioScience
Cue Biopharma
Lumicell, Inc.
Abramson Cancer Center at Penn Medicine
AbbVie
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shattuck Labs, Inc.
Risen (Suzhou) Pharma Tech Co., Ltd.
University Hospital, Tours
Hospices Civils de Lyon
Hospices Civils de Lyon
University of Exeter
Memorial Sloan Kettering Cancer Center
I-Mab Biopharma US Limited
SpringWorks Therapeutics, Inc.
Seagen Inc.
Beth Israel Deaconess Medical Center
City of Hope Medical Center
Sichuan Cancer Hospital and Research Institute
Mayo Clinic
ARCAGY/ GINECO GROUP
Institut Curie
Hospices Civils de Lyon
Daiichi Sankyo
Transgene
Mayo Clinic